Applicability of the UK DCD risk score in the modern era of liver transplantation: A US update

被引:2
|
作者
Wu, W. Kelly [1 ]
Ziogas, Ioannis A. [1 ]
Matsuoka, Lea K. [1 ]
Izzy, Manhal [2 ]
Alexopoulos, Sophoclis P. [1 ]
机构
[1] Vanderbilt Univ, Dept Surg, Div Hepatobiliary Surg & Liver Transplantat, Med Ctr, 801 Oxford House,1313 21st Ave South, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Dept Med, Div Gastroenterol Hepatol & Nutr, Med Ctr, Nashville, TN 37232 USA
关键词
donation after cardiac death; liver transplantation; primary nonfunction; risk stratification; United Network for Organ Sharing; CARDIAC DEATH; ISCHEMIC CHOLANGIOPATHY; CIRCULATORY-DEATH; MACHINE PERFUSION; ORGAN DONATION; FOLLOW-UP; DONORS; GRAFTS; RETRANSPLANTATION; EXPERIENCE;
D O I
10.1111/ctr.14579
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background Careful graft and recipient selection have resulted in improved outcomes in liver transplantation (LT) using donation after cardiac death (DCD) organs. The UK DCD Risk Score was established as a risk stratification tool to guide selection. Methods We evaluated the applicability of the UK DCD Risk Score in a contemporary US cohort of adult DCD LT recipients using the United Network for Organ Sharing registry (2011-2020). Results A total of 3,899 DCD LTs were included in our study (UK DCD Risk Score 0-5 points: 1,438 [36.9%], 6-10 points: 2,034 [52.2%]; 11-20 points: 427 [11.0%]). Compared to a score of 6-10 points, a score of 0-5 points was associated with decreased risk of graft loss (HR = .79, 95%CI: .68-.93, p = .004), while a score of 11-20 points was associated with increased risk of graft loss (HR = 1.26, 95%CI: 1.01-1.56, p = .04). The 5-year graft survival for patients with risk scores of 0-5, 6-10, and 11-20 were 75.9%, 71.8%, and 66.5%, respectively. The C-statistic for the UK DCD Risk Score in our contemporary cohort was .611. Conclusions The UK DCD Risk Score demonstrates a more limited ability to differentiate recipient outcomes in the modern era of DCD LT in the US. Acceptable long-term outcomes are achievable for patients stratified to the highest-risk group.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] THE UK-PBC RISK SCORE: DERIVATION AND VALIDATION OF A RISK SCORE TO PREDICT LIVER EVENTS IN THE UK-PBC RESEARCH COHORT
    Carbone, M.
    Sharp, S. J.
    Heneghan, M. A.
    Neuberger, J. M.
    Hirschfield, G. M.
    Burroughs, A. K.
    Thorburn, D.
    Bathgate, A.
    Aldersley, M.
    Adgey, C.
    Trembling, P.
    Williamson, K.
    Jopson, L.
    Lim, R. T.
    Wareham, N. J.
    Cordell, H. J.
    Alexander, G. J.
    Jones, J. E.
    Sandford, R. N.
    Mells, G. F.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S201 - S202
  • [42] Overall donor and recipient risk and not retrieval practice impact on outcomes after DCD liver transplantation - a comparative analysis between retrieval centres in UK
    Boteon, A. P. C. d. S.
    Schlegel, A.
    Kalisvaart, M.
    Boteon, Y. L.
    Abradelo, M.
    Mergental, H.
    Roberts, J. K.
    Mirza, D. F.
    Perera, M. T. P. R.
    Isaac, J.
    Muiesan, P.
    TRANSPLANTATION, 2018, 102 : 299 - 299
  • [43] An Update on Usage of High-Risk Donors in Liver Transplantation
    Muhammad, Haris
    Zaffar, Duha
    Tehreem, Aniqa
    Ting, Peng-Sheng
    Simsek, Cem
    Turan, Ilker
    Alqahtani, Saleh
    Saberi, Behnam
    Gurakar, Ahmet
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (01)
  • [44] Reply to Letter: "The Balance of Risk Score for Allocation in Liver Transplantation"
    Dutkowski, Philipp
    Schlegel, Andrea
    Muellhaupt, Beat
    Clavien, Pierre-Alain
    ANNALS OF SURGERY, 2014, 259 (02) : E35 - E35
  • [45] Better Graft Survival with no Ischemic Cholangiopathy in DCD Liver Transplantation in the UK using Normothermic Regional Perfusion (NRP)
    Oniscu, Gabriel C.
    Butler, Andrew
    Hunt, Fiona
    Large, Stephen
    Sutherland, Andrew
    Messer, Simon
    Currie, Ian
    Upon, Sarah
    Terrace, John
    Watson, Christopher J.
    TRANSPLANTATION, 2018, 102 : S413 - S413
  • [46] RE-WRITING THE DEFINITION OF HIGH-RISK AND FUTILE DCD LIVER TRANSPLANTATION WITH NRP
    Sherif, Ahmed E.
    Sutherland, Andrew
    Currie, Ian
    Hunt, Fiona
    Oniscu, Gabriel C.
    TRANSPLANT INTERNATIONAL, 2021, 34 : 158 - 158
  • [47] Adjuvant therapy after resection of colorectal liver metastases: the predictive value of the MSKCC clinical risk score in the era of modern chemotherapy
    Nuh N Rahbari
    Christoph Reissfelder
    Henning Schulze-Bergkamen
    Dirk Jäger
    Markus W Büchler
    Jürgen Weitz
    Moritz Koch
    BMC Cancer, 14
  • [48] Effects of immunosuppression on ABO incompatible liver transplantation outcomes in the modern era.
    Gordon, SA
    Uchiyama, K
    Datta, S
    Cameron, A
    Carmody, IC
    Kelly, B
    Ruiz, R
    Zimmerman, M
    Hassan, Y
    Farmer, DG
    Ghobrial, RM
    Busuttil, RW
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 374 - 374
  • [49] Adjuvant therapy after resection of colorectal liver metastases: the predictive value of the MSKCC clinical risk score in the era of modern chemotherapy
    Rahbari, Nuh N.
    Reissfelder, Christoph
    Schulze-Bergkamen, Henning
    Jager, Dirk
    Buchler, Markus W.
    Weitz, Jurgen
    Koch, Moritz
    BMC CANCER, 2014, 14
  • [50] The effect of immunosuppression on ABO incompatible liver transplantation outcomes in the modern era.
    Gordon, SA
    Uchiyama, K
    McDiarmid, SV
    Datta, S
    Lipshutz, G
    Cameron, A
    Carmody, IC
    Kelly, B
    Ruiz, R
    Zimmerman, M
    Yersiz, H
    Farmer, D
    Ghobrial, RM
    Busuttil, RW
    LIVER TRANSPLANTATION, 2005, 11 (07) : C36 - C36